Join to View Full Profile
1441 Eastlake AveLos Angeles, CA 90033
Dr. Algaze is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Sandra Algaze, MD is an accomplished Oncologist based in Los Angeles, California. She completed her Fellowship in Hematology and Medical Oncology at the University of Southern California/LAC+USC Medical Center. Prior to this, she did her Internship and Residency in Internal Medicine at the University of Miami/Jackson Health System. She is a highly published researcher, with work primarily focused on colorectal cancer and treatment appearing in esteemed journals like European Journal of Cancer, Journal for Immunotherapy of Cancer, and Oncogene. Dr. Algaze outstanding academic accomplishments have led to her induction into the Alpha Omega Alpha Honor Medical Society.
Education & Training
University of Southern California/Los Angeles General Medical Center (USC/LA General)Fellowship, Hematology and Medical Oncology, 2018 - 2021
University of Miami/Jackson Health SystemResidency, Internal Medicine, 2016 - 2018- University of Miami/Jackson Health SystemInternship, Internal Medicine, 2015 - 2016
Universidad Central del Caribe School of MedicineClass of 2015
Certifications & Licensure
CA State Medical License 2018 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society
Publications & Presentations
PubMed
- Pan-RAS inhibitors and polo-like kinase 1: promising targets in colorectal cancer.Priya Jayachandran, Andrew Elliott, Shivani Soni, Francesca Battaglin, Pooja Mittal
Oncogene. 2025-08-01 - 1 citationsComprehensive characterization of MCL-1 in patients with colorectal cancer: Expression, molecular profiles, and outcomes.Pooja Mittal, Francesca Battaglin, Yasmine Baca, Joanne Xiu, Alex Farrell
International Journal of Cancer. 2025-04-15 - 1 citationsGenetic Polymorphisms in MHC Classes I and II Predict Outcomes in Metastatic Colorectal Cancer.Pooja Mittal, Francesca Battaglin, Yan Yang, Shivani Soni, Sebastian Stintzing
International Journal of Molecular Sciences. 2025-03-12
Press Mentions
New Study Examines if ‘Inoperable’ Pancreatic Tumors Can Be Safely RemovedJanuary 27th, 2025- New Study Examines if ‘Inoperable’ Pancreatic Tumors Can Be Safely RemovedMarch 15th, 2024
Grant Support
- Robert A. Winn Diversity in Clinical Trials Award ProgramBristol Myers Squibb Foundation2021–2023
Professional Memberships
- Member
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
